Viewing nowCombinationAvaltan A Plus Tablet 5/80/10 mg
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.

MFDS item code 202006656 · Approved 2020.09.25 · Insurance code 657308420
Treatment of essential hypertension, improvement of dyslipidemia, prevention of cardiovascular disease
This medicine is used for patients with essential hypertension who have difficulty controlling blood pressure alone with amlodipine or valsartan. It also applies to patients with a high risk of cardiovascular disease or requiring treatment for dyslipidemia. The atorvastatin component helps reduce the risk of recurrence after myocardial infarction, stroke, and vascular surgery, and is also used to improve hypercholesterolemia and dyslipidemia. Therefore, this medicine is used as a suitable treatment for patients with combined cardiovascular disease risk and management of blood pressure and lipids.
Take 1 tablet once daily with water. If possible, it is recommended that you take it at the same time every day (e.g., in the morning). This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and atorvastatin. For patients taking an amlodipine/valsartan combination and atorvastatin as separate medicines, they may be switched to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination Before administering the amlodipine/valsartan combination, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, a direct switch to the amlodipine/valsartan combination may be considered when blood pressure is not adequately controlled with monotherapy using the individual components, as follows. ㆍ5/80 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. - Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more); however, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. - Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80 mg. The amlodipine/valsartan combination should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. - Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose. ▷ Atorvastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. The medicine may be taken at any time of day, with or without food. 1. Dyslipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are not available, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. - Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. - Elderly patients: Efficacy and safety in elderly patients aged 70 years or older are generally similar to those in the adult patient population.
This medicine can cause severe harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. If muscle-related symptoms, such as muscle pain or weakness, occur, the medicine should be stopped immediately, and a doctor should be consulted. Patients with severely impaired liver function or significantly decreased kidney function should avoid using this medication as it may be dangerous. Patients with allergies to the components of this drug or with certain genetic diseases should avoid taking it. Patients with low sodium or water levels in the body should improve their condition before taking this medicine and should closely monitor blood pressure and symptoms during treatment. This medicine can increase potassium levels in the blood, so if taken with potassium supplements or potassium-sparing diuretics, potassium levels should be checked frequently. Special care is needed when taking this medicine for heart disease patients, such as those with heart failure or after a myocardial infarction, and it should be used cautiously according to the doctor's instructions. Patients must undergo regular liver function tests and muscle-related tests while on this medicine, and report any unusual symptoms to healthcare providers immediately. Caution is needed when driving or operating machinery as dizziness or fatigue may occur. This medicine may interact with other drugs, so if currently taking other medications, healthcare providers must be informed, especially about concurrent use of certain antibiotics, antifungals, or antivirals. This medicine is not recommended for breastfeeding women, and it should be avoided during breastfeeding. The atorvastatin component can affect liver function; therefore, patients with a history of liver disease should use it even more cautiously, and should stop taking it immediately if symptoms of hepatitis appear. While taking this medicine, if symptoms such as muscle pain, muscle weakness, or fever occur, consult a doctor immediately, as these symptoms can indicate rare but serious muscle damage. Taking this medicine with certain foods, such as grapefruit juice, can alter the drug concentration, so it is advisable to limit grapefruit juice intake. Women who are pregnant or planning to become pregnant should not take this medicine and should use appropriate contraceptive methods.
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly sealed container to prevent exposure to air or moisture. It is best to keep it at room temperature between 1 to 30 degrees Celsius. This helps maintain the drug's effectiveness for a longer period.
White oval film-coated tablet
30 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Dongu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Dong Gu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.